Home » Topics » BioWorld Science

BioWorld Science
RSS

BUB1 biallelic mutations seen to cause microcephaly and developmental delay

Jan. 26, 2022

Molecular mimicry triggers multiple sclerosis

Jan. 25, 2022

Anixa and MolGenie report in vitro data on SARS-CoV-2 protease inhibitor

Jan. 25, 2022

AB1 protein targets TP53-mutated gastrointestinal tumors

Jan. 25, 2022

ImmVira leverages viral vectors to enable CAR-T therapy for solid tumors

Jan. 25, 2022

KIN-3248 shows efficacy against tumors with clinically relevant FGFR mutations

Jan. 25, 2022

PL-8177 shows promise in preclinical models of induced colitis

Jan. 25, 2022

Qualigen to develop G4-selective transcription inhibitor from UCL for cancer

Jan. 25, 2022

CBD inhibits SARS-CoV-2 replication during early stages of infection in mice

Jan. 25, 2022

Shanghai Newsky Biotechnology identifies PLA2G7 inhibitors

Jan. 25, 2022

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...